Literature DB >> 27599023

Topographic Quantification of the Transcorneal Electrical Stimulation (TES)-Induced Protective Effects on N-Methyl-N-Nitrosourea-Treated Retinas.

Ye Tao1, Tao Chen2, Zhong-Yu Liu3, Li-Qiang Wang1, Wei-Wei Xu1, Li-Min Qin1, Guang-Hua Peng1, Huang Yi-Fei1.   

Abstract

PURPOSE: To quantify the transcorneal electrical stimulation (TES)-induced effects on regional photoreceptors and visual signal pathway of N-methyl-N-nitrosourea (MNU)-treated retinas via topographic measurements.
METHODS: N-methyl-N-nitrosourea-administered mice received TES or sham stimulations and were subsequently subjected to electroretinography (ERG), multielectrode array (MEA), and histologic and immunohistochemistry examinations. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analyses were also performed to determine the mRNA levels of Bax, Bcl-2, Calpain-2, Caspase-3, brain-derived neurotrophic factor (BDNF), and ciliary neurotrophic factor (CNTF).
RESULTS: Amplitudes of ERG b-wave in the TES-treated mice were significantly larger than those in the sham controls (P < 0.01). Microelectrode array examination revealed that the photoreceptors in TES-treated retina were efficiently preserved (P < 0.01). Morphologic measurements showed that the central retina region was more consolidated than the other areas in the TES-treated mice. Together with the disproportionate distribution of immunostaining in retinal flat mounts, these findings indicated that different rescuing kinetics existed among regional photoreceptors. Compared with the sham controls, a significantly increased signal-to-noise ratio was also found in the TES-treated mice (TES100: 2.02 ± 1.12; TES200: 4.42 ± 1.51; sham: 0.25 ± 0.13; P < 0.01). Moreover, qRT-PCR measurements suggested that the altered expression of several apoptotic factors and neurotrophic cytokines was correlated with TES-induced protection.
CONCLUSIONS: Regional photoreceptors in the MNU-administered retinas exhibit different sensitivities to TES. Transcorneal electrical stimulation is capable of ameliorating MNU-induced photoreceptor degeneration and rectifying abnormalities in the inner visual signal pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27599023     DOI: 10.1167/iovs.16-19305

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa.

Authors:  Ava K Bittner; Kenneth Seger; Rachel Salveson; Samantha Kayser; Natalia Morrison; Patricia Vargas; Deborah Mendelsohn; Jorge Han; Hua Bi; Gislin Dagnelie; Alexandra Benavente; Jessica Ramella-Roman
Journal:  Acta Ophthalmol       Date:  2017-11-11       Impact factor: 3.761

2.  Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.

Authors:  Ava K Bittner; Kenneth Seger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-12-08       Impact factor: 3.117

Review 3.  Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review.

Authors:  Bernhard A Sabel; Josef Flammer; Lotfi B Merabet
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

4.  Protection of retinal function and morphology in MNU-induced retinitis pigmentosa rats by ALDH2: an in-vivo study.

Authors:  Weiming Yan; Pan Long; Dongyu Wei; Weihua Yan; Xiangrong Zheng; Guocang Chen; Jiancong Wang; Zuoming Zhang; Tao Chen; Meizhu Chen
Journal:  BMC Ophthalmol       Date:  2020-02-18       Impact factor: 2.209

5.  The Comparative Efficiency of Intraperitoneal and Intravitreous Injection of Hydrogen Rich Saline against N-Methyl-N-Nitrosourea Induced Retinal Degeneration: A Topographic Study.

Authors:  Ye Tao; Tao Chen; Wei Fang; Zhongjun Yan; Qinghua Yang; Yifei Huang; Linjun Yu; Lingling Fan
Journal:  Front Pharmacol       Date:  2017-08-29       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.